Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announces the completion of its previously announced acquisition of select clinical testing assets of Fresenius Medical Care’s wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States. With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Laboratories. Quest also expects to complete the acquisition of select dialysis-related water testing assets by the end of 2025.
Read the full article: Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care //
Source: https://www.prnewswire.com/news-releases/quest-diagnostics-completes-acquisition-of-clinical-testing-assets-from-fresenius-medical-care-302521113.html